Skip to main content

Vericel Corp

VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000887359

In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 7 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vericel Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
6 insiders, $2.48M in total
Insiders trading
6
Net value
−$2.48M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vericel Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vericel Corp
NameTitleLast reported holdingLast filingFilings, past year
McLaughlin Kevin FDirector18,300Aug 14, 20265
Halpin MichaelChief Operating Officer16,394Aug 5, 20268
Siegal JonathanPrincipal Accounting Officer1,078Jul 31, 20266
Hopper Jonathan MarkChief Medical Officer75,753Jun 30, 20266
Flynn Sean C.Chief Legal Officer1,647Jun 30, 20265
Mara Joseph Anthony JrChief Financial Officer16,009Jun 30, 20264
Wotton Paul KDirector18,802May 13, 20263
Zerbe Robert L MDDirector32,995May 1, 20261
Rubino Alan LDirector64,194May 1, 20262
Hagen HeidiDirector35,050May 1, 20262
Wright LisaDirector15,851May 1, 20261
Colangelo DominickPresident and CEO312,446Feb 26, 20262
Mahoney KarenChief Human Resources Officer1,854Dec 12, 20251
Gilman Steven CDirector11,000Oct 18, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2021 (view filing)Jun 302 daysHopper Jonathan MarkChief Medical OfficerSSale−134$57.14−$7.66K−0.3%39.3K after
Jul 14, 2021 (view filing)Jul 122 daysHalpin MichaelChief Operating OfficerSSale−20.0K$53.54−$1.07M−78.1%5.62K after
Jul 16, 2021 (view filing)Jul 151 dayFlynn Sean C.VP, General CounselSSale−10.0K$51.18−$511.8K−80.5%2.42K after
Jul 23, 2021 (view filing)Jul 212 daysFlynn Sean C.VP, General CounselSSale−2.80K$55.01−$154.0K−53.7%2.42K after
Aug 18, 2021 (view filing)Aug 162 daysHalpin MichaelChief Operating OfficerSSale−15.0K$48.03−$720.5K−72.7%5.62K after
Aug 31, 2021 (view filing)Aug 274 daysFlynn Sean C.VP, General CounselSSale−7.20K$55.11−$396.8K−74.9%2.42K after
Oct 1, 2021 (view filing)Sep 301 dayGilman Steven CDirectorSSale−5.00K$48.85−$244.3K−58.8%3.50K after
Oct 28, 2021 (view filing)Oct 262 daysHalpin MichaelChief Operating OfficerSSale−10.0K$50.57−$505.7K−63.7%5.70K after
Oct 28, 2021 (view filing)Oct 271 dayGilman Steven CDirectorSSale−5.00K$50.57−$252.8K−58.8%3.50K after
Dec 1, 2021 (view filing)Nov 292 daysGilman Steven CDirectorSSale−5.00K$39.17−$195.8K−58.8%3.50K after
Dec 22, 2021 (view filing)Dec 20-222 daysHopper Jonathan MarkChief Medical OfficerSSale−15.9K$40.11−$637.0K−26.7%43.5K after3 lots
Mar 3, 2022 (view filing)Mar 12 daysHopper Jonathan MarkChief Medical OfficerSSale−16.7K$41.43−$693.5K−25.4%49.2K after2 lots
May 2, 2022 (view filing)Apr 293 daysGilman Steven CDirectorSSale−900$30.94−$27.8K−14.8%5.20K after
Oct 18, 2022 (view filing)Oct 144 daysSiegal JonathanPrincipal Accounting OfficerSSale−331$25.47−$8.43K−27.4%875 after
Jan 12, 2023 (view filing)Jan 102 daysColangelo DominickPresident and CEOSSale−39.9K$27.13−$1.08M−20.3%157.1K after
Feb 3, 2023 (view filing)Feb 21 daySiegal JonathanPrincipal Accounting OfficerSSale−330$31.00−$10.2K−32.8%675 after
Jun 26, 2023 (view filing)Jun 224 daysZerbe Robert L MDDirectorSSale−3.00K$36.00−$108.0K−8.0%34.4K after10b5-1
Jul 17, 2023 (view filing)Jul 143 daysZerbe Robert L MDDirectorSSale−1.00K$38.84−$38.8K−2.9%33.4K after10b5-1
Nov 17, 2023 (view filing)Nov 152 daysSiegal JonathanPrincipal Accounting OfficerSSale−662$37.70−$25.0K−33.7%1.30K after
Nov 17, 2023 (view filing)Nov 152 daysZerbe Robert L MDDirectorSSale−300$38.02−$11.4K−0.9%33.1K after2 lots10b5-1
Nov 22, 2023 (view filing)Nov 202 daysHopper Jonathan MarkChief Medical OfficerSSale−5.00K$36.40−$182.0K−8.6%53.0K after10b5-1
Dec 1, 2023 (view filing)Nov 301 dayHalpin MichaelChief Operating OfficerSSale−17.4K$35.41−$617.8K−95.5%827 after10b5-1
Dec 8, 2023 (view filing)Dec 6-72 daysColangelo DominickPresident and CEOSSale−24.4K$34.14−$832.9K−12.1%176.7K after2 lots10b5-1
Dec 15, 2023 (view filing)Dec 13-142 daysColangelo DominickPresident and CEOSSale−24.0K$35.58−$853.8K−12.4%170.0K after2 lots10b5-1
Dec 15, 2023 (view filing)Dec 141 dayWotton Paul KDirectorSSale−5.00K$37.31−$186.6K−15.7%26.8K after
Dec 15, 2023 (view filing)Dec 13-142 daysFlynn Sean C.SVP, General CounselSSale−1.54K$34.42−$52.9K−25.6%4.47K after2 lots
Jan 16, 2024 (view filing)Jan 124 daysZerbe Robert L MDDirectorSSale−2.20K$38.09−$83.8K−6.6%30.9K after10b5-1
Jan 19, 2024 (view filing)Jan 17-182 daysColangelo DominickPresident and CEOSSale−33.5K$38.28−$1.28M−16.4%170.0K after2 lots10b5-1
Jan 24, 2024 (view filing)Jan 222 daysZerbe Robert L MDDirectorSSale−8.00K$41.85−$334.8K−23.6%25.9K after3 lots10b5-1
Jan 29, 2024 (view filing)Jan 254 daysZerbe Robert L MDDirectorSSale−200$44.02−$8.80K−0.8%25.7K after10b5-1
Jan 30, 2024 (view filing)Jan 291 dayZerbe Robert L MDDirectorSSale−2.30K$44.22−$101.7K−9.0%23.4K after
Feb 16, 2024 (view filing)Feb 14-152 daysColangelo DominickPresident and CEOSSale−35.0K$47.92−$1.68M−16.7%174.0K after2 lots10b5-1
Feb 22, 2024 (view filing)Feb 202 daysZerbe Robert L MDDirectorSSale−722$50.01−$36.1K−3.0%23.4K after10b5-1
Mar 11, 2024 (view filing)Mar 74 daysSiegal JonathanPrincipal Accounting OfficerSSale−1.63K$45.00−$73.5K−53.9%1.40K after
Mar 13, 2024 (view filing)Mar 112 daysHalpin MichaelChief Operating OfficerSSale−7.87K$44.71−$352.0K−89.2%949 after10b5-1
Mar 15, 2024 (view filing)Mar 87 daysFlynn Sean C.SVP, General CounselSSale−8.12K$45.33−$367.9K−98.0%167 afterAmended10b5-1
Mar 15, 2024 (view filing)Mar 13-142 daysColangelo DominickPresident and CEOSSale−35.0K$44.35−$1.55M−15.2%194.9K after2 lots10b5-1
Mar 29, 2024 (view filing)Mar 272 daysZerbe Robert L MDDirectorSSale−3.28K$51.57−$169.0K−12.3%23.4K after10b5-1
Apr 19, 2024 (view filing)Apr 17-182 daysColangelo DominickPresident and CEOSSale−35.0K$45.53−$1.59M−15.2%195.3K after2 lots10b5-1
May 17, 2024 (view filing)May 15-162 daysColangelo DominickPresident and CEOSSale−35.0K$48.76−$1.71M−13.7%220.8K after2 lots10b5-1
May 21, 2024 (view filing)May 201 dayHopper Jonathan MarkChief Medical OfficerSSale−10.0K$49.99−$499.9K−14.7%58.1K after10b5-1
Jun 14, 2024 (view filing)Jun 12-132 daysColangelo DominickPresident and CEOSSale−35.0K$43.61−$1.53M−13.7%220.8K after2 lots10b5-1
Jun 24, 2024 (view filing)Jun 20-244 daysFlynn Sean C.Chief Legal OfficerSSale−15.0K$45.11−$676.6K−96.9%487 after3 lots10b5-1
Jul 9, 2024 (view filing)Jul 54 daysSiegal JonathanPrincipal Accounting OfficerSSale−545$45.00−$24.5K−34.5%1.03K after10b5-1
Jul 16, 2024 (view filing)Jul 124 daysMara Joseph Anthony JrChief Financial OfficerSSale−5.00K$50.00−$250.0K−25.7%14.4K after10b5-1
Jul 18, 2024 (view filing)Jul 162 daysFlynn Sean C.Chief Legal OfficerSSale−15.0K$52.18−$782.7K−95.5%707 after10b5-1
Jul 19, 2024 (view filing)Jul 17-182 daysColangelo DominickPresident and CEOSSale−35.0K$51.48−$1.80M−13.7%220.9K after2 lots10b5-1
Aug 9, 2024 (view filing)Aug 72 daysMcLaughlin Kevin FDirectorSSale−7.00K$45.94−$321.6K−37.0%11.9K after2 lots10b5-1
Aug 16, 2024 (view filing)Aug 14-152 daysColangelo DominickPresident and CEOSSale−35.0K$45.71−$1.60M−13.7%220.9K after2 lots10b5-1
Sep 5, 2024 (view filing)Sep 32 daysHopper Jonathan MarkChief Medical OfficerSSale−10.0K$49.83−$498.3K−14.7%58.2K after10b5-1